Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
- PMID: 11147588
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
Abstract
Background: Sentinel lymph node dissection (SLND) has been a promising new technique in breast carcinoma staging, but could be unreliable in certain patient subsets. The current study assessed whether age, preoperative chemotherapy, tumor size, and/or previous excisional biopsy influenced the identification of sentinel nodes (SLNs) or the reliability of a node-negative SLND in predicting a node negative axilla.
Methods: Eighty-two patients who had clinically negative axillae underwent SLND followed by Level I/II axillary lymph node dissection (ALND). SLNDs were performed using both technetium-99m (Tc-99m) labeled colloid and isosulfan blue dye. SLNs were analyzed by hematoxlyin and eosin and immunocytochemical techniques.
Results: SLNs were successfully identified in 80% of patients. Mapping success was decreased among postmenopausal women but was not influenced by preoperative chemotherapy, large tumor size, or previous excisional biopsy. Of the 31 successfully mapped, node positive patients, 5 had false negative (FN) SLNDs (overall FN rate = 16%). Of the 9 successfully mapped patients who had received preoperative chemotherapy and had positive axillary nodes, 3 had FN SLND (FN rate = 33%). The presence of clinically positive lymph nodes before chemotherapy did not predict which patients would have a subsequent FN SLND. T3 tumor size, but not previous excision, was associated significantly with increased FN rate, although the FN rate for previous excision was 11%. No FN SLND occurred with T1/T2 tumors that were not excised previously and had not received preoperative chemotherapy.
Conclusions: Preoperative chemotherapy was associated with an unacceptably high FN rate for SLND. While larger tumor size also was associated with FN SLND, this effect might have been due to preoperative chemotherapy use in these patients. Small sample size precluded determining whether excisional biopsy before mapping increased FN SLND rates independently.
Similar articles
-
Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.Ann Surg Oncol. 2000 Jan-Feb;7(1):21-7. doi: 10.1007/s10434-000-0021-1. Ann Surg Oncol. 2000. PMID: 10674444 Clinical Trial.
-
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.J Clin Oncol. 2000 Oct 15;18(20):3480-6. doi: 10.1200/JCO.2000.18.20.3480. J Clin Oncol. 2000. PMID: 11032588 Clinical Trial.
-
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932. JAMA. 2013. PMID: 24101169 Free PMC article. Clinical Trial.
-
Potential and pitfalls of sentinel node detection in breast cancer.Recent Results Cancer Res. 2000;157:237-49. doi: 10.1007/978-3-642-57151-0_21. Recent Results Cancer Res. 2000. PMID: 10857177 Review.
-
Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401. doi: 10.1097/00000658-199509000-00016. Ann Surg. 1995. PMID: 7677468 Free PMC article. Review.
Cited by
-
Breast Cancer OncoGuia.Clin Transl Oncol. 2010 Feb;12(2):113-38. doi: 10.1007/s12094-010-0477-9. Clin Transl Oncol. 2010. PMID: 20156781 No abstract available.
-
Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study.Mol Clin Oncol. 2016 Nov;5(5):507-510. doi: 10.3892/mco.2016.1025. Epub 2016 Sep 21. Mol Clin Oncol. 2016. PMID: 27882235 Free PMC article.
-
Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.JAMA Oncol. 2017 Apr 1;3(4):549-555. doi: 10.1001/jamaoncol.2016.4163. JAMA Oncol. 2017. PMID: 27918753 Free PMC article. Review.
-
Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer.Cancer Imaging. 2019 Dec 26;19(1):91. doi: 10.1186/s40644-019-0279-4. Cancer Imaging. 2019. PMID: 31878958 Free PMC article.
-
Early breast cancer.Int J Clin Oncol. 2006 Apr;11(2):108-19. doi: 10.1007/s10147-006-0564-7. Int J Clin Oncol. 2006. PMID: 16622745 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous